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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYCTG repeat expansion in DMPK, the cause of myotonic dystrophy type 1 (DM1), frequently results in hypermethylation and reduced
SIX5 expression. The contribution of hypermethylation to disease pathogenesis and the precise mechanism by which SIX5 expression
is reduced are unknown. Using 14 different DM1-affected human embryonic stem cell (hESC) lines, we characterized a differentially
methylated region (DMR) near the CTGs. This DMR undergoes hypermethylation as a function of expansion size in a way that is specific
to undifferentiated cells and is associated with reduced SIX5 expression. Using functional assays, we provide evidence for regulatory
activity of the DMR, which is lost by hypermethylation and may contribute to DM1 pathogenesis by causing SIX5 haplo-insufficiency.
This studyhighlights the power of hESCs in diseasemodeling and describes aDMR that functions both as an exon coding sequence and as
a regulatory element whose activity is epigenetically hampered by a heritable mutation.INTRODUCTION
Myotonic dystrophy type 1 (DM1) is an autosomal domi-
nant muscular dystrophy that affects a wide range of
body systems (DM1 [OMIM: 160900]). It results from a
trinucleotide CTG repeat expansion (50–4,000 copies) in
the 30 UTR of the dystrophia myotonica protein kinase
gene (DMPK) (Aslanidis et al., 1992; Brook et al., 1992).
The CTG repeat region, which resides within a CpG island
(CGI), commonly results in hypermethylation and the
spread of heterochromatin when expanded (Cho et al.,
2005; Filippova et al., 2001; Steinbach et al., 1998). Hyper-
methylation is largely age- and tissue-specific and does not
necessarily correlate with expansion size in somatic cells of
patients (Lo´pez Castel et al., 2011; Spits et al., 2010). In
addition, when the CTG repeats expand, they commonly
result in a reduction in the expression of a neighboring
gene, SIX5 (Klesert et al., 1997, 2000; Korade-Mirnics
et al., 1999; Sarkar et al., 2000, 2004; Thornton et al.,
1997). The contribution of hypermethylation to disease
pathogenesis is still not fully understood, nor is the precise
mechanism by which CTG expansion leads to SIX5 reduc-
tion in cis. Using a wide range of DM1-affected human em-
bryonic stem cell (hESC) lines, we aimed to uncover the
mechanistic relationship between CTG expansion, aber-
rant methylation, and reduced expression of SIX5 in DM1.Stem CRESULTS
Derivation and Characterization of DM1 hESCs
Fourteen different mutant hESC lines were established
from DM1-affected preimplantation embryos. This exclu-
sive set of DM1-affected cell lines, which displays the
typical characteristics of hESCs (Figure S1), represents a
wide range of maternally and paternally inherited expan-
sions, bearing from 180 to more than 2,000 CTG repeats
(Table 1).
Characterization of a Disease-Associated,
Differentially Methylated Region Upstream of the
CTG Repeats in DM1 hESCs
To assess whether normal and expanded alleles differ in
their DNA methylation patterns in undifferentiated cells,
we employed a methylation-sensitive Southern blot assay
that relies on the digestion of a SacI-HindIII fragment
with either MspI or its methylation-sensitive isoschizomer,
HpaII. Because the SacI-HindIII fragment contains 26
MspI/HpaII recognition sites, of which only one is located
downstream of the repeats (Figures 1A and 1B), the diges-
tion of this segment with either HpaII or MspI facilitates
the identification of methylation upstream of the CTGs.
Using this test on wild-type (WT) and affected hESCs, we
show that abnormal methylation is already established inell Reports j Vol. 5 j 221–231 j August 11, 2015 j ª2015 The Authors 221
Table 1. DM1-Affected hESC Line Collection
HESC Line Family Parental Origin of Expansion CTG Copy Number SNP1 SNP2 SNP3 SNP4
SZ-DM1 A paternal 1000 G/T C/G C/G
SZ-DM2 A paternal 430,500,1000 G/T G/T C/G
SZ-DM3 B maternal 2000 C/G
SZ-DM4 C paternal 180 G/T C/G
SZ-DM5 D paternal 300 G/T G/T C/G
SZ-DM6 A paternal 1060 G/T G/T C/G C/G
SZ-DM7 E paternal 300 G/T G/T C/G
SZ-DM8 B maternal 400,1900,2000 C/G
SZ-DM9 F paternal 180 G/T C/G C/G
SZ-DM11 A paternal 500 C/G
SZ-DM12 A paternal 630 C/G
SZ-DM14 H maternal 2000 C/G
SZ-DM20 A paternal 300 G/T G/T C/G C/G
LIS-DMa G maternal 600–1600 C/G
Information related to the newly established DM1 hESC lines, including family code, parental origin of expansion, CTG repeat copy number, and informative
SNPs. SNP1 (rs915915) and SNP2 (rs635299) are intronic polymorphisms located 1.5 kb and 650 bp upstream of the repeats, respectively. SNP3 (rs527221)
and SNP4 (rs2014377) are exonic polymorphisms located in exon 10 and exon 3 of the DMPK and SIX5 genes, respectively. Alleles that were confirmed to be
in linkage disequilibrium with the CTG expansion by haplotype analysis are marked in bold. See also Figure S1 for a full characterization of DM1 hESC lines.
aProvided by the Racine IVF Unit, Tel-Aviv Sourasky Medical Center.the undifferentiated state and that it is exclusively acquired
by expansions greater than 300 CTG repeat copies (Fig-
ure 1C; Figure S2A). In addition, we find that, in hESCs, a
clear association exists between expansion size and extent
of methylation. That is, the larger the expansion, the larger
the region of methylated DNA. Interestingly, the 1.3- and
1.6-kb bands (arrows in Figures 1C and S2A) indicate that
the sites adjacent to the CTG repeats only become methyl-
ated in the larger expansions, attesting to a distinct pattern
of acquisition of methylation in expanded alleles.
To understand the methylation events in expanded
alleles at a higher resolution, we first defined the 50 border
of the differentially methylated region (DMR) by bisulfite
colony sequencing in WT hESCs and found that the
DMR only begins 700 base pairs (bp) into the CGI,
900 bp upstream of the CTGs (intron 13 of DMPK) (Fig-
ure S3). We then determined methylation levels in region
E of the DMR in DM1 hESC lines by allele-specific bisulfite
sequencing, utilizing an informative SNP that resides
within this region. Allelic association between the informa-
tive SNP and the expansion was carried out by haplotype
analysis using parental DNAs in each cell line. Using this
approach, we found that repeat expansion size strongly
correlates with hypermethylation of this region (650 bp222 Stem Cell Reports j Vol. 5 j 221–231 j August 11, 2015 j ª2015 The Autupstream from the repeats), ranging from 0% (<300
CTGs) to over 88% (1,000 CTGs) (r = 0.94114; Spearman’s
rank correlation, p < 0.01) (Figures 2A and 2B; Figure S4A).
Absolute methylation levels in cell lines with no informa-
tive SNPs in this region further corroborated these results
(Figure S4B). Furthermore, statistical validation showed
that low levels of abnormal methylation can already be
observed in expansions of 300 CTG copies as opposed to
normal alleles in informative cell lines, confirming the
Southern blot results (p < 0.01 by paired t test; Figure 2C).
Taken together with the Southern blot analysis (which
indicated that the last region to undergo methylation was
the region adjacent to the CTG repeats), these results indi-
cate that abnormal methylation of the DMR begins from
the 50 end of the CGI (already methylated) and spreads
toward the CTG repeats.
To further substantiate our findings, we explored
whether reprogramming somatic cells to induced pluripo-
tent stem cells (iPSCs) would recapitulate aberrant methyl-
ation patterns specific to undifferentiated cells. Primary
fibroblasts with a CTG expansion of approximately 2,000
repeats, which were only partly methylated upstream of
the repeats, were reprogrammed according to Takahashi
et al. (2007). This resulted in the establishment of threehors
Figure 1. DNA Methylation Analysis
Upstream of the CTGs by Southern Blot
Analysis
(A) Schematic illustration of the human
DM1 locus.
(B) Detailed description of the 30 portion of
the DM1 locus, spanning from exon 11 to
the CTG repeats (1.8 kb long in WT
alleles [20 CTGs] and up to 8 kb long in
expanded alleles). Twenty-six HpaII/MspI
recognition sites, embeddedwithin the SacI-
HindIII restriction fragment, are indicated
by black vertical bars. Also indicated are
the probe used for the Southern blot
analysis (pDM567), two polymorphic sites
(SNP1 and SNP2), six proximal genomic re-
gions analyzed in this study by bisulfite
sequencing/pyrosequencing (A, C, D, E,
F, and G), region D–F representing the DMR,
and twoputative CTCFbindingsites upstream
and downstream of the repeats (green ellip-
ses). The numbers under genomic regions A,
C, D, E, F, and G indicate the relative distance
from the SacI restriction site (position 1
corresponds with chr19:46,275,123 on the
hg19 human genome assembly).
(C) Representative Southern blots from WT
(SZ-RB2 and SZ-BRCA4) of, altogether,
seven WT hESC lines examined and DM1-
affected hESC lines with small (<300 CTGs,
SZ-DM9 and SZ-DM4), intermediate (300
CTGs, SZ-DM20), moderate to large (450–
650 CTGs, SZ-DM11 and SZ-DM12), and
particularly large expansions (>650 CTGs,
SZ-DM6 and SZ-DM14). To determine CTG
repeat number by Southern blot analysis,
genomic DNA was double-digested with
SacI and HindIII and then hybridized with
the pDM567 probe, resulting in an 1.8-kb
(normal allele with 20 CTGs) and a larger
fragment (expanded allele) (left lane
in each panel). To investigate aberrant
methylation upstream of the repeats, the
SacI-HindIII fragments were further processed by parallel restriction with MspI (+MspI) and its methylation-sensitive isoschizomer, HpaII
(+HpaII). Marked by arrows are methylated 1.3-kb, 1.6-kb, and larger fragments. The CTG repeat number and passage number (in pa-
rentheses) are indicated for each cell line at the top of each blot.
See also Figure S2 for additional Southern blots of DM1 hESC lines and Figure S3 for identification of the CpG Island 50 methylation border in
WT hESCs.iPSC clones (iPS-4, iPS-19, and iPS-24), each featuring
typical characteristics of pluripotent stem cells and a
normal karyotype (Figure S1). Using methylation-sensitive
Southern blot analysis, we found that reprogramming led
to an appreciable gain of abnormal methylation in all iPS
cell clones but no change in expansion size (Figure S2B).
In addition, the bisulfite pyro-sequencing results indicatedStem Ca marked increase in methylation levels of the mutant
allele immediately upstream of the CTG repeats in DM1-re-
programmed iPS cells relative to parental fibroblasts
(region F; Figure S5E, bottom). Therefore, our results sug-
gest that aberrant methylation patterns are unique to un-
differentiated DM1-affected cells and can be re-established
following cell reprogramming.ell Reports j Vol. 5 j 221–231 j August 11, 2015 j ª2015 The Authors 223
Figure 2. Allele-Specific Methylation Levels in the DMR Correlates with Expansion Size in DM1 hESCs
(A) Allele-specific bisulfite sequencing of the expanded allele within the DMR (region E, 488–777 bp upstream of the repeats, overlapping
the SNP2 site). Full circles correspond to methylated CpGs, whereas empty circles represent unmethylated CpGs. For each cell line,
methylation levels (%) were determined by the analysis of at least 20 molecules by bisulfite sequence. Methylation levels (%), passage
number, and CTG expansion size are indicated for each cell line.
(B) Graphical summary of the results in (A), showing the significant correlation that exists between expansion size and methylation levels
(r = 0.94114; Spearman’s rank correlation test, p < 0.01).
(C) Intermediate-sized expansions (300 CTG repeats) of SZ-DM5, SZ-DM7, and SZ-DM20 samples exhibit significantly higher methylation
levels than their WT counterpart alleles (p < 0.01 by paired t test). n, number of cell lines examined. Error bars represent SD.
See also Figure S3 for identification of the CpG Island 50 methylation border in WT hESCs and Figure S4 for allele-specific bisulfite
sequencing of the WT allele in informative DM1 hESC lines, and for absolute bisulfite sequencing within non-informative DM1 hESC lines
and iPSC clones.Association between Aberrant Methylation and Local
Gene Transcription
To link abnormal methylation with disease pathogenesis,
we identified informative SNPs within exon 10 of DMPK
(SNP3) and exon 3 of SIX5 (SNP4) and associated gene
expression with mutated alleles in DM1 hESCs (Figure 3A;
Table 1). In parallel, wemonitored allele-specific alterations
in SIX5 expression in DM1 iPSCs that carried a polymor-224 Stem Cell Reports j Vol. 5 j 221–231 j August 11, 2015 j ª2015 The Autphism in SIX5 but not inDMPK.We utilized these polymor-
phisms to employ a commonly used method that relies on
pair-wise comparisons between genomic DNA and cDNA
sequences to identify allelic expression imbalances (AEIs)
(Ben-David et al., 2011; Figure 3B). Our analysis identified
a striking inverse correlation (r = 0.84; Spearman’s rank cor-
relation coefficient, p = 0.00134) between the methylation
level in the E region of the DMR and SIX5 expressionhors
Figure 3. Association between Aberrant
Methylation and SIX5 Gene Transcription
(A) Schematic illustration of the human
DM1 locus, including the DMPK gene and its
adjacent neighbor gene, SIX5. SNP3 and
SNP4 are located in the coding regions of
DMPK and SIX5, respectively.
(B) Identification of SIX5 AEIs. SNP4
sequencing results (shaded) in representa-
tive genomic DNA (gDNA) and cDNA
samples from WT and DM1-affected hESCs
(SZ-RB26 and SZ-DM2, respectively). The
expression ratio between the alleles in each
cell line was estimated using PeakPicker2
software.
(C) Cell line-specific comparison of
expanded allele methylation levels in re-
gion E (as determined by allele-specific and
absolute bisulfite sequencing) with the
mean SIX5 expression ratio of expanded
allele/WT allele. The assayed cell lines,
WT (SZ-RB26) and DM1-affected hESCs,
were arbitrarily ranked into groups accord-
ing to the levels of aberrant methylation in
region E. SIX5 expression by the expanded
allele correlates well with methylation
levels (region E) in 11 pluripotent cell
lines (r = 0.84; Spearman’s rank correlation,
p < 0.01). The correlation was found to be
statistically significant (p = 0.001) ac-
cording to a permutation test (50,000
permutations). Values of allele-specific
transcription of SIX5 were determined
based on the analysis of two to three biological replicas for each cell line. SD was calculated for each cell line.
(D) Graphical summary of the tabulated results in (C).
(E) Absolute methylation levels in region E, as determined by bisulfite pyrosequencing, and the SIX5 allelic expression ratio in in vitro-
differentiated cardiomyocytes from WT (SZ-RB26, n = 2) and SZ-DM14 (n = 4) hESCs (p < 0.01 by paired t test). The 13 CpG sites tested are
indicated by shaded squares according to methylation levels (see colored legend). Mean absolute methylation levels across all tested CpG
positions are indicated to the right in each line.
See also Figure S5 for DMPK expression, methylation downstream to the CTGs, expression of cardiospecific markers, and CTCF binding
analysis.(Figures 3C and 3D). That is, the higher the levels of
methylation upstream from the repeats, the lower the
SIX5 expression levels that were assayed. Importantly, no
correlation was found between hypermethylation and
allele-specific alterations in DMPK expression (Figure S5A).
Furthermore, we could not find an association between the
reduction in SIX5 expression andmethylation downstream
of the CTGs (region G) or at the promoter region of SIX5
(Figure S5B), regardless of expansion size. Therefore, we car-
ried on with our study, focusing on the DMR region.
To characterize the epigenetic status of the DMR in the
context of myotonic dystrophy disease symptoms, we
generated functional cardiomyocytes by in vitro differenti-
ation, taking into account the frequent involvement of car-Stem Cdiac complications in DM1 patients (Lund et al., 2014;
Martorell et al., 1997; Sovari et al., 2007). Using an opti-
mized protocol for cardiac differentiation (Burridge et al.,
2014), we established a large number of contracting cardi-
omyocytes from WT and DM1 hESCs that express
cardiac-specific markers, as confirmed by RT-PCR (Fig-
ure S5C). We examined DMR hypermethylation and
allele-specific reduction in SIX5 expression in the WT and
DM1 in vitro-differentiated cardiomyocytes. Notably,
DMR methylation levels (E region) were much higher in
DM1-affected cardiomyocytes compared with the WT
control cells, and this was accompanied by reduced expres-
sion of SIX5 from the expanded allele (30% of the WT
allele) (Figure 3E). Therefore, it appears that increasedell Reports j Vol. 5 j 221–231 j August 11, 2015 j ª2015 The Authors 225
methylation upstream of the CTG repeats, in the coding re-
gion of DMPK, hampers the expression of the downstream
proximal gene, SIX5, in DM1 hESCs and in in vitro-differ-
entiated cardiomyocytes.
Functional Association between DMR
Hypermethylation and the Reduction in SIX5
Expression
To address the mechanistic association between aberrant
methylation levels and the decrease in SIX5 expression,
we first ruled out the previously suggested hypothesis
that SIX5 expression is regulated by the insulator binding
protein CTCF (Filippova, 2001, 2008). CTCF is displaced
when its recognition site is hypermethylated (Filippova,
2008). Using chromatin immunoprecipitation (ChIP)
analysis, we first confirmed the occupancy of CTCF to its
binding site upstream of the CTG repeats in both WT
and affected hESCs (Figure S5D). No CTCF enrichments
were found downstream of the CTGs (Figure S5D). Next,
by bisulfite pyro-sequencing of the bound and input frac-
tions in the CTCF binding site (region F; Figure 1B), we
validated CTCF differential binding affinity to its unme-
thylated recognition site upstream of the CTG repeats (Fig-
ure S5E, top). Then we searched for a correlation between
hypermethylation of the CTCF binding site, as determined
by bisulfite pyro-sequencing, and allele-specific reduction
of SIX5 mRNA in the affected cell lines (Figure 3D).
However, no correlation was found (Figure S5E, bottom).
Therefore, we ruled out the possibility that loss of CTCF
binding contributed to the reduction in SIX5 expression
by hypermethylation, as proposed previously (Filippova,
2001, 2008).
Next we asked whether hypermethylation by CTG
expansion hampers the activity of a putative SIX5 regula-
tory element within the DMPK gene. Using both in vivo
and in vitro functional assays, we explored the regulatory
role of the DMR sequence.
Using a zebrafish functional assay, we explored whether
the DMR sequence could function as an active regulatory
element in vivo. Despite the lack of a SIX5 homolog in ze-
brafish, we show that the DMR sequence alone (Figure 4A,
fragment I) drives GFP expression. This is in contrast to
the other fragments (SIX5 promoter and the entire region;
Figure 4A, fragments II and III), which failed to drive
GFP expression. GFP expression under the regulation of
the DMR, which, although weak, was restricted to the
heads of transgenic animals and was predominantly ex-
pressed in the epidermis (beneath the eye), hindbrain,
and branchial arches at 48 and 72 hr post-fertilization
(hpf) (Figure 4B).
We then examined whether the DMR could drive lucif-
erase reporter gene (luc+) expression by transient transfec-
tion in three different cell lines (293T, COS-7, and HepG2).226 Stem Cell Reports j Vol. 5 j 221–231 j August 11, 2015 j ª2015 The AutWe show that, although the empty vector completely lacks
reporter gene activity, insertion of the DMR alone (Fig-
ure 4A, fragment I) results in a 10- to 15-fold increase
over basal activity obtained either by the insertion of the
SIX5 promoter (Figure 4A, fragment II), the entire region
spanning from the DMR to the SIX5 promoter (Figure 4A,
fragment III), or the DMR in an opposite orientation. The
basal activity obtained by the entire region (extending
from the DMR to the SIX5 promoter) suggests an inhibi-
tory effect of a downstream sequence that is not apparent
in vivo. Together, these transient expression experiments
suggest that the DMR alone is capable of strongly acti-
vating reporter gene expression in vitro when in a
proper orientation and independent of the SIX5 promoter
(Figure 4C).
To examine the effects of methylation on the regulatory
activity of this region, we in vitro-methylated theDMR vec-
tor using the CpG methyltransferase M.SssI and used it in
the transfection assay (validated by digestion with the re-
striction endonuclease HpaII, which is sensitive to methyl-
ation; data not shown). Strikingly, methylation of the
construct led to complete silencing of reporter gene expres-
sion in all cell lines (Figure 4C), indicating that DNA
methylation of the DMR results in the loss of its ability to
stimulate transcription.
To demonstrate a possible regulatory role for the DMR
in a disease-relevant tissue, we examined whether the
DMR alone is sufficient to drive the expression of an
eGFP reporter in in vitro-differentiated cardiomyocytes.
Undifferentiated DMR-eGFP-transfected hESC clones
were generated and propagated, resulting in neomycin-
resistant colonies with a variegated expression of eGFP.
High eGFP-expressing hESCs were isolated by fluores-
cence-activated cell sorting (FACS) and induced to differ-
entiate into contracting cardiomyocytes. This approach
allowed us to successfully generate DMR-driven fluores-
cent green-emitting, functioning cardiomyocytes. Taken
together with the observation that the regulatory activity
of the DMR is methylation dependent (Figure 4C)
and that an inverse correlation between DMR hyperme-
thylation and SIX5 expression exists in differentiated
cardiomyocytes (Figure 3E), we confirmed the potential
role of the DMR as a distal regulatory element in a
disease-relevant cell type (Figure 4D; Movies S1, S2, S3,
and S4).
Together, we provide compelling evidence for the
discovery of an epigenetically controlled regulatory
element within the coding sequence of DMPK that is
capable of driving gene expression in transgenic animals
as well as in various cell lines/types, including cardiac
muscle cells. Its regulatory activity most likely affects
SIX5 expression and is hampered by the gain of aberrant
methylation.hors
Figure 4. Functional Assay for the Regu-
latory Role of the DMR
(A) Schematic illustration describing the
different inserts tested in this study. Frag-
ments I, II, and III designate the DMR
sequence in both orientations, the SIX5
promoter, and the entire region that spans
from the DMR to the SIX5 promoter (in-
cludes 12 repeats), respectively. The size of
each fragment is indicated in parentheses.
(B) Zebrafish enhancer assay for the DMR
region. GFP expression was observed in the
epidermis and branchial arches of zebrafish
embryos (marked by arrows) at 48 and 72 hr
post-fertilization (hpf). Scale bars, 100 mm.
(C) Relative luciferase activity from tran-
siently transfected 293T, COS-7, and HepG2
cells. Luciferase activity was measured 48 hr
after transfection. Renilla expression levels
were used to normalize cell number, trans-
fection efficiency, and general effects on
gene transcription. Data were normalized to
luciferase levels of the empty vector pGL3
Basic. Bar graphs stand for mean values
(indicated on top of each bar) and SD from
three independent experiments with three
technical replicates each (paired t test,
**p < 0.01, ***p < 0.001).
(D) EGFP expression driven by the DMR in
stably transfected undifferentiated hESCs
(top) and in in vitro-differentiated con-
tracting cardiomyocytes derived from them
(bottom) (magnification, 2003; scale bars,
100 mm).
See also Movies S1, S2, S3, and S4 pre-
senting fluorescent green-emitting func-
tioning cardiomyocytes driven by the DMR.DISCUSSION
Here we report on 14 different mutant hESC lines, termed
DM1 hESCs, that were derived from DM1-affected preim-
plantation embryos. Previous studies employed DM1
hESCs to explore the causal role of CTG expansion on neu-
rite formation and neuromuscular connections and for
characterizing the somatic instability of the CTG repeats
in undifferentiated cells (De Temmerman et al., 2008; Mar-
teyn et al., 2011; Seriola et al., 2011). However, neither of
these studies addressed the consequences of CTG expan-
sion on DNA methylation and how this change may
contribute to disease pathogenesis. In addition, a compre-
hensive study characterizing aberrant methylation in a
wide range of tissues from DM1 aborted fetuses and post-
mortem samples demonstrates that hypermethylation is
largely tissue- and age-specific but not necessarily corre-
lated with expansion size, making it difficult to assign aStem Cfunction to abnormal methylation in disease pathogenesis
(Lo´pez Castel et al., 2011).
Taking advantage of a large set of DM1 hESC lines
comprised of maternally and paternally inherited expan-
sions bearing from 180 to more than 2,000 CTG repeats,
we finely characterized a disease-associated DMR, 650 bp
upstream to the CTG repeats, that abnormally gains
methylation in a way that strongly correlates with expan-
sion size (r = 0.94114; Spearman’s rank correlation, p <
0.01). We show that this association, which is restricted
to undifferentiated cells, is triggered by expansions of
more than 300 CTG repeats and is tightly linked with
allele-specific reduction in SIX5 (but not DMPK) transcrip-
tion (r = 0.84; Spearman’s rank correlation coefficient,
p = 0.00134), as determined by allele expression imbal-
ances. Furthermore, we show that the relationship between
expansion size, methylation extent, and allele reduction in
SIX5 is reproduced in patient-derived iPSCs following cellell Reports j Vol. 5 j 221–231 j August 11, 2015 j ª2015 The Authors 227
reprogramming and ismaintained in in vitro-differentiated
cardiomyocytes, a disease-relevant cell type. Together, our
findings in DM1 hESCs and patient-derived iPSCs corre-
spond with the decline in SIX5 expression in DM1 patients
and with the expression of various aspects of DM1 pathol-
ogy in SIX5 heterozygote mice (Klesert et al., 2000; Sarkar
et al., 2000, 2004; Wakimoto et al., 2002). Moreover, they
are consistent with the negative cis effect of large CTG ex-
pansions on the induction of hypermethylation in trans-
genic mice (Brouwer et al., 2013; Lo´pez Castel et al.,
2011), pointing to a role for chromatin modification in
DM1 pathogenesis. However, it should be noted that hy-
permethylation patterns in transgenic mice are similar,
but not identical, to those observed in DM1 individuals
(Lo´pez Castel et al., 2011) and that, in contrast to our study,
the reduced expression in SIX5 is uncorrelated with expan-
sion size in transgenic mice (Brouwer et al., 2013). The dis-
crepancies between both studies may stem from epigenetic
variations that exist between species or may be attributed
to transgene integration site effects.
Given the aforementioned relationships, we aimed to
mechanistically associate DMR hypermethylation with
allele-specific reduction in SIX5 expression. Initially, we
ruled out the possibility that the CTG expansion leads to
the reduction in SIX5 expression by interfering with
CTCF binding via hypermethylation, as proposed previ-
ously (Filippova et al., 2001). Our findings do not support
the proposition that CTCF normally functions as an insu-
lator binding protein at the DM1 locus to guarantee the in-
dependent expression ofDMPK and SIX5 (Cho et al., 2005).
Although this difference may stem from the different cell
types employed in each study, our findings are well in
linewith the report of Brouwer et al. (2013) regarding trans-
genic mice that showed no effect of CTG expansion size on
CTCF binding.
In light of these results regarding CTCF, we questioned
whether methylation spreading may exert its effect by an
alternative mechanism: by hampering the activity of a pu-
tative regulatory element for SIX5 that resides within the
DMPK gene. For this purpose, we examined the ability of
the DMR to drive reporter gene expression in vivo and
in vitro. In vivo, we found that the DMR is capable and suf-
ficient to drive GFP expression in the heads of transgenic
fish, predominantly in the epidermis, hindbrain, and bran-
chial arches. We speculate that the partial similarity in the
tissue specificity of reporter gene activity in zebrafish to
that of SIX5 expression in the branchial arches of devel-
oping mice (10.5 days post-coitum [d.p.c.]) (Heath et al.,
1997; Klesert et al., 2000) may possibly explain the lack
of facial expression and the difficulties in speech and swal-
lowing that are typical in patients.
In vitro, we demonstrated that the DMR can drive lucif-
erase expression in three different cell lines (293T,COS-7,228 Stem Cell Reports j Vol. 5 j 221–231 j August 11, 2015 j ª2015 The Autand HepG2) and markedly enhances reporter gene activity
(10- to 15-fold increase) compared with basal activity ob-
tained with either the SIX5 promoter, the entire region
that surrounds the CTG repeats (12 repeats), or the DMR
in an opposite orientation. Although our in vitro assays
point to the potential role of this regulatory element as a
promoter sequence, there is no evidence to support
this in publically available datasets in hESCs or any
other cell type examined. Therefore, we suggest that this
element most likely acts as a proximal enhancer rather
than a distal promoter for SIX5 transcription. Importantly,
to establish the relevance of methylation to the regula-
tory function of this region, we verified that in vitro
methylation of the DMR completely silenced reporter
gene activity in all examined cell lines. These results
indicate that aberrant methylation is, in fact, mechanisti-
cally responsible for the cis reduction in SIX5 expression.
Lastly, given the frequent involvement of cardiac conduc-
tion defects in patients and in SIX5 heterozygote mice
(Martorell et al., 1997; Sarkar et al., 2000; Wakimoto
et al., 2002), we illustrate that the DMR is capable of
driving eGFP expression in in vitro-derived transgenic
cardiomyocytes.
Our results are in line with the identification of this
region in publically available data as a regulatory ele-
ment by FAIRE (formaldehyde-assisted isolation of
regulatory elements); DNaseI hypersensitive site mapping;
local enrichment in monomethylation of histone 3 at
lysine 4 (H3K4me1), acetylation of histone 3 at lysine 27
(H3K27Ac) and Pol2A; and the clustering of tissue-specific
transcription factors. In conclusion, our functional assays
suggest that SIX5 activity is finely tuned by the activity of
a narrow DMR that is located upstream of the repeats, in
the coding region of DMPK. This putative regulatory zone
may ultimately prove to be an essential target for the treat-
ment of DM1 clinical symptoms that are attributed to SIX5
downregulation.
Together, this study shows a mechanistic association be-
tween CTG expansion size, hypermethylation, and the
reduction in SIX5 expression. It demonstrates how a dis-
ease-causing mutation in one gene (CTG expansion in
DMPK) can affect the expression of a different gene (SIX5)
by epigenetically modifying a flanking sequence that plays
a dual function: a protein coding sequence and a regulatory
element for a neighboring gene. Our findings, therefore,
clearly illustrate how an unstable repeat expansion leads
to the spread of methylation by the loss of the 50 boundary
of a CpG island.
Lastly, this study highlights the power of mutant hESCs
in deciphering mechanistic relations that are exclusive in
undifferentiated cells, such as the relation betweenmethyl-
ation spreading and expansion size. These associations
probably would not have been revealed if not for a largehors
and heterogeneous cohort of mutant hESC lines that were
available for analysis. Moreover, this study emphasizes the
strength of mutant hESCs in disease modeling by affording
the exploration of human-based, disease-relevant tissues,
like impaired cardiomyocytes, that are otherwise inacces-
sible for research.EXPERIMENTAL PROCEDURES
hESC Line Derivation, Characterization, and
Spontaneous Differentiation In Vitro
The use of DM1-affected embryos, derived from preimplantation
genetic diagnosis (PGD) treatment, for hESC derivation was per-
formed in compliance with protocols approved by the National
Ethics Committee. All cell lines were established at the Shaare
Zedek Medical Center (87/07), apart from LIS-DM, which was
provided by the Racine IVF Unit, Tel-Aviv SouraskyMedical Center
(7/04-043). Cell line derivation and characterization were carried
out as described previously (Eiges et al., 2007). All DM1 hESC lines
were examined for typical characteristics of hESCs (primers for RT-
PCR analysis are listed in Table S1).Expression of Undifferentiated Specific Markers
Undifferentiated cell cultures were examined for the expression of
undifferentiated cell-specific markers by immunostaining using
monoclonal mouse OCT4 (Santa Cruz Biotechnology, catalog no.
sc-5279, 1:50 dilution) or TRA-1-60 (Santa Cruz, catalog no. sc-
21705, 1:50 dilution) together with Cy3-conjugated goat anti-
mouse polyclonal antibodies (Jackson Immunostaining, catalog
no. 115-035-062, 1:100 dilution). Nuclear staining was performed
withHoechst 33258 (Sigma, catalog no. 861405). Staining for alka-
line phosphatase was carried out using an alkaline phosphatase kit
(Sigma Diagnostics, catalog no. 86R-1KT), according to the manu-
facturer’s protocol.DM1 iPSC Derivation
Four retroviral vectors expressing OCT4, SOX2, KLF4, and c-MYC
were packaged individually in 293T cells. Infectious viruses were
collected 24 and 48 hr post-transfection and added immediately
to primary fibroblasts (catalog no. GM03132A, Coriell Cell Repos-
itories). Four days after infection, the cells were placed onmytomy-
cin C-treatedmouse embryonic fibroblasts (MEFs) andmaintained
in hESCmedium.Manual isolation of single clones was carried out
approximately 30 days post-transfection, resulting in stable cell
lines with a hESC-like morphology.RT-PCR
Total RNA was isolated from the cells by TRI reagent extraction,
and then 1–2 mg RNAwas reverse-transcribed by random hexamer
priming andMulti Scribe reverse transcriptase (ABI). Amplification
was performed using the primers listed in Table S1 using Super-
ThermTaqDNApolymerase (Jain Biologicals). For allele expression
ratio analysis, DNA and cDNA PCR products were purified and
sequenced on an ABI 3130XL genetic analyzer. Sequencing chro-
matograms were analyzed using PeakPicker2 software.Stem CSouthern Blot Analysis
Genomic DNAs (10–25 mg) were digested with SacI and HindIII
(Fermentas) restriction endonucleases, separated on 0.8% agarose
gels, blotted onto Hybond N+ membranes (Amersham), and hy-
bridized with a PCR Dig-labeled pDM576 probe (primers: 50-GCT
AGG AAG CAG CCA ATG AC-30 and 50-CAT TCC CGG CTA CAA
GGA C-30). For analysis of DNA methylation, triple digests of
SacI and HindIII were performed together with either the methyl-
ation-sensitive enzyme HpaII or its methylation-insensitive iso-
schizomer MspI (Fermentas).
SNP Analysis
Genomic DNA from each cell line was PCR-amplified (primers are
listed in Table S1) and compared with parental DNAs at the SNP
site to determine allelic associations with the CTG expansion.
Bisulfite Sequencing
Genomic DNA (2 mg) was modified by bisulfite treatment (EZ DNA
methylation kit, Zymo Research) and amplified by FastStart DNA
polymerase (Roche). Amplified products were cloned, and single
colonies were analyzed for CpGmethylation by direct sequencing
(ABI 3130). For pyrosequencing, PCRproductswere analyzed using
PyroMak Q24 (QIAGEN). Primers are listed in Table S1.
Cardiomyocyte Differentiation
WT and DM1-affected hESC lines were induced to differentiate
into human cardiomyocyte cells according to Burridge et al.
(2014). Briefly, hESC lines grown on a mouse embryonic fibroblast
feeder layer were passaged into Essential 8medium on vitronectin-
coated culture vessels and then passaged with 0.5 mM EDTA. For
differentiation, the medium was changed to CDM3, consisting of
RPMI 1640 medium (catalog no. 11875, Life Technologies),
500 mg/mlO. sativa-derived recombinant human albumin (catalog
no. A0237, Sigma-Aldrich), and 213 mg/ml L-ascorbic acid 2-phos-
phate (Sigma-Aldrich). The medium was changed every other day
(48 h). On days 0–2, the medium was supplemented with 6 mM
CHIR99021 (LC Laboratories). On day 2, themediumwas changed
to CDM3 supplemented with 2 mMWnt-C59 (Selleck Chemicals).
The medium was changed to CDM3 on day 4 and every other
day. Contracting cells were noted from day 7. The human
cardiomyocytes were collected for analysis by TrypLE Express
(Life Technologies) and were examined for expression of three car-
diac markers (MYH-7, GATA-4, and NKX 2-5). Primers are listed in
Table S1.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation was performed using the Up-
state EZ ChIP kit according to the manufacturer’s protocol, with
slight modifications. In brief, cells were harvested and then fixed,
quenched, and washed in 50-ml tubes. Sonication was carried out
using Vibra Cell VCX130 with a 3-mm microtip and 30%
amplitude in 5 cycles of 10 min and 30 min rest on ice. Immuno-
precipitation was performed using an anti-CTCF antibody (Up-
state, catalog no. 07-729). Real-time PCR was carried out on an
ABI 7900HT instrument (primers are listed in Table S1). DDCt
values were normalized according to a positive control (FXN) to
account for differences in precipitation efficiency.ell Reports j Vol. 5 j 221–231 j August 11, 2015 j ª2015 The Authors 229
Zebrafish Functional Assay
Three fragments (DMR, the SIX5 promoter, and the entire region)
were cloned into the E1b GFP-Tol2 vector containing an E1b min-
imal promoter, followed by GFP (Li et al., 2010; Birnbaum et al.,
2012). Briefly, the zebrafish were injected following standard
procedures (Nusslein-Volhard and Dahm 2002) into at least 100
embryos/construct along with Tol2 mRNA (Kawakami, 2005) to
facilitate genomic integration. GFP expression was observed and
annotated at 48 and 72 hours post-fertilization (hpf). All animal
care was approved by the Animal Care and Use Committee of
Ben-Gurion University.
Reporter Gene Assay
Cell transfections of the pGL3-based reporter constructs (primers
for vector constructions are listed in Table S1) were performed in
three different cell lines (293T, COS-7, and HepG2) in 24-well
plates using TransIT-LT1 transfection reagent (MIRUS) according
to the manufacturer’s recommendations. Cells were cotransfected
with 100 ng pGL3-based reporter constructs carrying each of the
different fragments or an empty vector and with 10 ng of Renilla
luciferase plasmid with luciferase driven from a thymidine kinase
(TK) promoter. Luciferase activity was measured in triplicate 48 h
after transfection using the Dual-Luciferase reporter assay (Prom-
ega) in a MiniLumat LB 9506 luminometer (EG&G Berthold). To
control for transfection efficiency, firefly luciferase activity was
normalized to that of Renilla luciferase. p Values were obtained
using a two-tailed, non-paired t test (p = 0.05).
In Vitro Methylation
Methylation of the pGL3 vector carrying the DMR was performed
by CpG methyltransferase (M.SssI, New England Biolabs). The
methylase reaction was performed with the addition of the
compound S-adenosylmethionine (SAM). The extent of methyl-
transferase activity was determined by digestion with the methyl-
ation-sensitive endonuclease HpaII and its insensitive iso-
schizomer MspI.
hESC Transfection
The DMR region was cloned into a basic eGFP-N1 plasmid, which
lacks a promoter or an enhancer sequence. A WT hESC line was
transfected with the eGFP-N1-DMR plasmid or an empty plasmid
using LT1-TransIT transfection reagent (MIRUS) according to the
manufacturer’s protocol. Stably transfected hESC clones were
generated by the use of 100–150 mg G418. DMR-eGFP-transfected
hESC clones were induced to differentiate into functional cardio-
myocytes following FACS.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures, one table, and
four movies and can be found with this article online at http://
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